The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
Үндсэн зохиолчид: | , , , , , , |
---|---|
Бусад зохиолчид: | |
Формат: | Conference item |
Хэл сонгох: | English |
Хэвлэсэн: |
Elsevier
2020
|